Thousand Oaks · Seed–Late Stage · 6 people tracked
Find your way into Amgen Ventures
4,071 people in our graph share verified history with the Amgen Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Through its Start-Up Network Program, Amgen sponsors life sciences incubators in key biotech innovation clusters and, in alignment with Amgen Ventures, provides funding and scientific support to early-stage life sciences and biotech start-ups. Since 2015 the program has supported over 20 companies, offering mentoring, scientific interaction, networking, potential collaboration, and access to innovation within the incubator community through a competitive selection process.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from curated & public directories
What they invest in
from 21 of 25 portfolio companiesBiotech ×15Healthtech ×12Deep Tech ×7AI & Machine Learning ×6Medical Devices ×6Digital Health ×5Logistics & Supply Chain ×2Advanced Manufacturing ×1
HQs:United States×18
Investments · 25 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 22023 · 22022 · 52021 · 32020 · 22019 · 118 dated
Nkarta is a biotech company developing allogeneic CAR NK cell therapies for autoimmune diseases, aiming to offer safer and more accessible alternatives to autologous CAR-T treatments.
BiotechHealthtechSouth San Francisco, US
Paul Hastings(Executive Officer, Director)inPaul H.inMatthew Plunkett(Executive Officer)inPaul J. Hastings(Chief Executive Officer)in
BoardMichael Dybbs(Director)Jill Carroll(Director)in
Co-investorsNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSR One Capital ManagementLogosNorwest Venture Partners+1 more
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)
BoardDonald Tang(Director)
Co-investorsEvolution VC PartnersFlucas VenturesLifeforce CapitalLux CapitalMenlo VenturesNew Enterprise Associates (NEA)+10 more
The Amgen Foundation funds and runs science education programs, providing teachers with research equipment and training and offering hands-on and virtual learning opportunities to students and scholars.
BiotechEdTechImpact & Social Good
Big Hat Bio develops therapeutics under development across multiple programs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Peyton Greenside(Executive Officer, Director)inMark DePristo(Executive Officer, Director)in
BoardFrancisco Gimenez(Director)inSteve Kafka(Director)Vineeta Agarwala(Director)inRobert Chess(Director)
Co-investors8VCAndreessen HorowitzBOLD LongevityFlucas VenturesGRIDS CapitalAME Cloud Ventures+5 more
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)inJeffrey Verboon(Founding Scientist, Computational Biology)inAnsu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Co-founder)in
Co-investors8VCAndreessen HorowitzArtis VenturesGlobal BioAccess FundHAWKTAILPfizer Venture Investments+6 more
Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.
BiotechDeep TechHealthtechHatfield, US
Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)Brian McVeigh(Executive Officer, Director)in
BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)
Co-investorsNew Enterprise Associates (NEA)4BIO CapitalHatteras Venture PartnersJDRF T1D FundNorthpond VenturesTakeda Ventures+1 more
Intermountain Health is a healthcare provider offering primary, pediatric, and specialty care services to patients, with a focus on preventive care and wellness.
Digital HealthHealthtech
Co-investorsEPIC VENTURESMerck Global Health Innovation Fund
Ember Life Sciences applies its temperature-control heating and cooling technology to healthcare logistics through the Ember Cube, a self-refrigerated, cloud-based shipping box with real-time location tracking and temperature monitoring for cold-chain payloads at 2°C–8°C.
HealthtechIoTLogistics & Supply ChainWestlake Village, US
Clayton Alexander(Executive Officer, Director)Brian Bejarano(Executive Officer)inAnn Marie Hyllengren(Executive Officer)
BoardMichael Kaufmann(Director)Timothy White(Director)James DeNaut(Director)
Co-investorsCarrier VenturesSea Court CapitalTDF Ventures
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in
Co-investors20/20 HealthCare Partners LLCFlucas VenturesTachyon VenturesVU Venture PartnersDolby Family VenturesFounders Fund
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsAir Street CapitalLux CapitalObvious VenturesLeaps by Bayer
Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.
BiotechDigital HealthHealthtech
Mark Sylvester(Chief Financial Officer)inAndrew Warner(Vice President, Product)inMonica Zarb(Vice President, Business Development)inDurand Van Arnem(Vice President, Engineering)inAlan Rope(Medical Director)in
Co-investorsCanaan PartnersDreamers VCEcho Health VenturesGV (Google Ventures)Illumina VenturesKaiser Permanente Ventures+7 more
HealthtechCambridge, US
COLIN HILL(Executive Officer, Director)inIYA KHALIL(Executive Officer)inTHOMAS NEYARAPALLY(Executive Officer)MARK POTTLE(Executive Officer)inCAROL MCCALL(Executive Officer)inBRUCE CHURCH(Executive Officer)in
Co-investorsAlexandriaEcho Health Ventures
OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.
Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain
Co-investorsOxford Investment Opportunity Network (OION)Ally Bridge GroupAltium CapitalDroia VenturesFrazier Healthcare PartnersNovo Holdings+2 more
Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.
AI & Machine LearningBiotechDeep TechHealthtech
Piers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)Dipti Thakkar(Chief Operating Officer)in
Co-investorsAltium CapitalClavystBioDecheng CapitalDroia VenturesFrazier Life SciencesKiwoom Investment+5 more
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsHighlight CapitalBlackRockBlackstone Life SciencesClarus VenturesFrazier Healthcare PartnersGreenspring Associates+4 more
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsAmorChemGenesys CapitalJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovations+2 more
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inBurak YILMAZ(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)
Co-investorsAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesHOF CapitalHummingbird VenturesSAV (Scale Asia Ventures)+2 more
Mindset Medical develops medical-grade software that uses remote photoplethysmography (rPPG) and deep learning to measure vital signs such as heart rate and respiratory rate through the camera on a patient's own smartphone, tablet, or computer.
AI & Machine LearningDigital HealthHealthtechMedical DevicesPhoenix, US
Mark L. Whitehouse(Executive Officer)inMitchell A. Foster(Executive Officer, Director, Promoter)Nicholas Theodore(Director)Joel Barthelemy(Director)
BoardJAMES GOULKA(Director)inBRIAN BURNS(Director)in
Co-investorsGrayhawk CapitalAZ Venture Capital Inc.NOVA PrimeQuesta CapitalXcellerant Ventures
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalMitsui Global InvestmentSanofi VenturesSV Health Investors+7 more
Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
BiotechBoston, US
Tasuku Kitada(Executive Officer, Director, Promoter)inJacob Becraft(Executive Officer, Director, Promoter)inSamta Kundu(Executive Officer)in
BoardJeb Keiper(Director)inAla Alenazi(Director)inPegah Ebrahimi(Director)in
Co-investorsJIC Venture Growth InvestmentsKinnevikPlayground GlobalANRIFPVICONIQ+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Ember TechnologiesGPB ScientificImago BioSciences, Inc.Khan Academy’s online learning websitesLabXchange
Exits · 3
2 IPOs · 1 acquisitionsNkarta, Inc.NASDAQ: NKTXSenti BiosciencesNASDAQ: SNTIInversagoacq. by Novo Nordisk
Portfolio news
latest coverage across their companies
Hummingbird · daysofobservance.com · Sep 4, 2026
Nkarta, Inc. · marketbeat.com · Aug 17, 2026
GNS Healthcare · chiefhealthcareexecutive.com · Aug 14, 2026
Ember LifeSciences · latimes.com · Aug 12, 2026
Senti Biosciences · kalkine.com.au · Jul 31, 2026
Ember Technologies · biospace.com · May 27, 2026
Cartography Biosciences · finsmes.com · May 7, 2026
Frequently asked questions
- How many investments has Amgen Ventures made?
- Amgen Ventures has 25 tracked investments, 3 of which have exited, including 3 dated in the last 24 months.
- What stage does Amgen Ventures invest at?
- Amgen Ventures invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Amgen Ventures's typical check size?
- Amgen Ventures typically writes checks of $1M – $3M.
- What sectors does Amgen Ventures focus on?
- Amgen Ventures focuses on Biotech, Healthtech.
- Where is Amgen Ventures located?
- Amgen Ventures is headquartered in Thousand Oaks, US.
Media · Podcasts & interviews
from their channelIgG4-RD Explained: From Delayed Diagnosis to Improving Care
Amgen
AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research
Amgen
Images
Similar investors
Legendary Ventures is a venture capital firm focused on consumer, retail, and technology (CRT) companies, combining the expertise of venture capitalists and retail executives to support portfolio companies and identify acquisition partners.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.
Celesta Capital is a venture capital firm that invests in deep tech companies at the forefront of science and engineering.
Quadrille is an independent investment manager focused on venture capital and growth equity, investing globally in technology and healthcare assets.
HM Venture Partners is a healthcare venture capital firm backing high-growth biotech and medtech companies worldwide across all stages, with three funds under management.